# HAII

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/haii

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.haii.co.kr
- Total disclosed funding: $8.2M
- Latest round: Series B (Nov 23, 2022)
- Investors on record: 9

## About

Based in Seoul, South Korea, and founded in 2016, HAII Corp., Ltd., aka HAII,  provider of digital therapeutics solutions, such as digital companion software and chat messenger services, to diagnose and treat patients with mental health issues, ADHD, and speech disorders. In November 2022, HAII raised KRW 7.5 billion in Series B funding, led by KB Securities, KB Investment, and Capstone Partners, with GeneN Investment Partners, Timewise Investment, and Dongwha Pharmaceutical.

The company's product line includes Anzeilax, Alzguard, Forme, and PATAKA, a mind checkup digital treatment medicine to cure mental illnesses such as dementia, depression, anxiety disorder, and ADHD, and applies a research-evidenced AI interaction strategy to enable patients to treat mental illness.

## Funding rounds

- Series B, Nov 23, 2022, $5.6M — KB Investment, Capstone Partners, CJ Investment, KB Securities, Dongwha Pharmaceutical, GeneN Investment Partners
- Series A, Sep 16, 2020, $2.6M — KB Investment, Capstone Partners, KB Securities, Honest Ventures, D.CAMP (inactive), We Venture Partners

## Investors

- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Series A, Series B
- Capstone Partners (https://capitalatlas.ai/funds/capstone-partners) — Series A, Series B
- KB Securities (https://capitalatlas.ai/funds/kb-securities) — Series A, Series B
- Honest Ventures (https://capitalatlas.ai/funds/honest-ventures) — Series A
- D.CAMP (inactive) — Series A
- We Venture Partners (https://capitalatlas.ai/funds/we-venture-partners) — Series A
- CJ Investment (https://capitalatlas.ai/funds/cj-investment) — Series B
- Dongwha Pharmaceutical — Series B
- GeneN Investment Partners (https://capitalatlas.ai/funds/genen-investment-partners) — Series B